GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » PS Ratio

HSTC (HST Global) PS Ratio : (As of Nov. 08, 2024)


View and export this data going back to 2002. Start your Free Trial

What is HST Global PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, HST Global's share price is $0.912. HST Global's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00. Hence, HST Global's PS Ratio for today is .

The historical rank and industry rank for HST Global's PS Ratio or its related term are showing as below:

HSTC's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.06
* Ranked among companies with meaningful PS Ratio only.

HST Global's Revenue per Sharefor the three months ended in Jun. 2024 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00.

During the past 13 years, HST Global's highest 3-Year average Revenue per Share Growth Rate was 187.10% per year. The lowest was -44.80% per year. And the median was 11.80% per year.

Back to Basics: PS Ratio


HST Global PS Ratio Historical Data

The historical data trend for HST Global's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global PS Ratio Chart

HST Global Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HST Global Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HST Global's PS Ratio

For the Biotechnology subindustry, HST Global's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HST Global's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HST Global's PS Ratio distribution charts can be found below:

* The bar in red indicates where HST Global's PS Ratio falls into.



HST Global PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

HST Global's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.912/0
=

HST Global's Share Price of today is $0.912.
HST Global's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


HST Global  (OTCPK:HSTC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


HST Global PS Ratio Related Terms

Thank you for viewing the detailed overview of HST Global's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HST Global Business Description

Traded in Other Exchanges
N/A
Address
150 Research Drive, Hampton, VA, USA, 23666
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Executives
Wesley D. Tate officer: CFO and Secretary C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell director, officer: CEO and Chairman C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc 10 percent owner 429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun director, 10 percent owner, officer: CEO TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King 10 percent owner FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang 10 percent owner FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd director 746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra director 1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp 10 percent owner
Alan Lew director, 10 percent owner, officer: President 2 DOGWOOD DR, SCARSDALE NY 10583

HST Global Headlines